With an ageing population addressing conditions such as arthritis becomes more and more important.
Chronic inflammation doesn't just impact those with arthritis however and contributes to a broad spectrum of diseases including arthritis, psoriasis, diabetes, allergy, connective tissue diseases, and heart disease. Researchers felt that despite the range of current therapeutics on offer, there was an unmet clinical need as treatments such as corticosteroids, though often effective, are associated with serious side effects.
A research team at the Universities of Strathclyde and Glasgow have taken the novel approach of searching for anti-inflammatory agents produced by pathogens during their battle to avoid elimination by the host.
This novel approach has led to their discovery of ES-62, a glycoprotein that is secreted by filarial nematodes, highly successful parasites of vertebrates including humans. The team has demonstrated that ES-62 is a potent, broad spectrum anti-inflammatory molecule which effectively reduces inflammation whilst leaving essential defence mechanisms intact.
The work is more than just promising with further research able to produce small molecule derivatives (SMDs) that exhibit anti-inflammatory activity in vivo.